- ^
Ahmadi A, Khalili M, Hajikhani R, Naserbakht M (април 2011). ?New morpholine analogues of phencyclidine: chemical synthesis and pain perception in rats”.
Pharmacology, Biochemistry, and Behavior
.
98
(2): 227?33.
PMID
21215770
.
S2CID
24650035
.
doi
:
10.1016/j.pbb.2010.12.019
.
- ^
Abiero A, Botanas CJ, Custodio RJ, Sayson LV, Kim M, Lee HJ, et?al. (март 2020). ?4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels”.
Psychopharmacology
.
237
(3): 757?772.
PMID
31828394
.
S2CID
209169410
.
doi
:
10.1007/s00213-019-05412-y
.
- ^
Colestock T, Wallach J, Mansi M, Filemban N, Morris H, Elliott SP, et?al. (фебруар 2018). ?Syntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues”.
Drug Testing and Analysis
.
10
(2): 272?283.
PMID
28513099
.
doi
:
10.1002/dta.2213
.
- ^
?3-MeO-PCMo”
. New Synthetic Drugs Database. Архивирано из
оригинала
2016-07-03. г
. Приступ?ено
2016-02-09
.
- ^
Mitsuoka T, Hanamura K, Koganezawa N, Kikura-Hanajiri R, Sekino Y, Shirao T (2019). ?Assessment of NMDA receptor inhibition of phencyclidine analogues using a high-throughput drebrin immunocytochemical assay”.
Journal of Pharmacological and Toxicological Methods
.
99
: 106583.
PMID
31082488
.
doi
:
10.1016/j.vascn.2019.106583
.